Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Malindo Feedmill Tbk. (MAIN) vs Organon Pharma Indonesia Tbk. (SCPI)

Malindo Feedmill Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Malindo Feedmill Tbk. dan Organon Pharma Indonesia Tbk.: Malindo Feedmill Tbk. diperdagangkan di Rp670 (kapitalisasi pasar 1,54 T, volume 24 jam 1,9 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Malindo Feedmill Tbk. jauh lebih besar — sekitar 14,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

MAINSCPI
Kapitalisasi Pasar
1,54 T104,4 M
Volume
1,9 jt
Lot
19,02 rb
Perputaran
1,28 M
Harga Rata-rata
674,35
Nilai Transaksi
1,28 M
Harga Ekuilibrium Indikatif
670
Volume Ekuilibrium Indikatif
302

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

MAIN
Lihat detail
SCPI
Lihat detail

Tentang Malindo Feedmill Tbk.

PT Malindo Feedmill Tbk (the Company) was established within the framework of Law No. 1 of 1967 and Law No. 11 of 1970 regarding Foreign Capital Investment. The Company was established under its original name PT Gymtech Feedmill on June 10, 1997. The company's name changed to PT Malindo Feedmill in year 2000. The company’s articles of association were amended several times, the lates on Jul 28 2005, regarding among other increasing in paid up capital share.

Selengkapnya di halaman MAIN

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI